openPR Logo
Press release

Biologics Safety Testing Market Future Forecast with Advance Technologies by Top Companies – Lonza, Charles River Laboratories, Cytovance Biologics, Eurofins, Merck Group, WuXi Biologics, Sartorius, Toxikon Corporation

05-09-2019 02:37 PM CET | Health & Medicine

Press release from: The Insight Partners

Biologics Safety Testing Market

Biologics Safety Testing Market

Growing pharmaceutical and biotechnology industry, rising investments in research and development by key players in the life sciences industry, and rising number of new drug entering into the market are few factors driving the biologics safety testing market. However, stringent government regulations and regulatory body norms for approval of biosimilars and high cost of drug development are some factors that may restrict the market growth.

Biologics are advanced drugs used in treatment of cancer, cardiovascular, rheumatoid arthritis, and other diseases. Biologics covers large molecules such as monoclonal antibodies, recombinant proteins and safety of these molecules ensures patient safety as these are used in the treatment of above mentioned diseases. Biologic drugs are produced from living organisms, it include recombinant proteins, tissues, genes, allergens, cells, blood components, blood, and vaccines.

Get Sample Copy Of Report@

Major Key Players In Biologics Safety Testing Market :

• Avance Biosciences Inc.
• Charles River Laboratories International, Inc.
• Cytovance Biologics, Inc.
• Eurofins Scientific Se
• Lonza Group Ltd.
• Merck KGaA
• SGS S.A.
• Wuxi Apptec
• Sartorius AG
• Toxikon Corporation
• Thermo Fisher Scientific Inc.
• Pace Analytical Services Inc.

The report also includes the profiles of key Biologics Safety Testing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

Market Scope:

"Global Biologics Safety Testing Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of Biologics Safety Testing market with detailed market segmentation by product & services, application, test type and geography. The global Biologics Safety Testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Biologics Safety Testing market players and offers key trends and opportunities in the market.

Speak With Industrial Expert@

Market Segments:

1. The global biologics safety testing market is segmented based on product & services, test type and application.

2. Based on product & services, the market is divided into kits & reagents, services, and instruments.

3. Based on test type, the biologics safety testing market is segmented into endotoxin tests, sterility tests, cell line authentication and characterization tests, cell line authentication, bioburden tests, residual host contaminant detection tests, adventitious agent detection tests, and others.

4. On the basis of application, the market is divided into vaccine development, blood products testing, cellular & gene therapy, tissue and tissue-related products testing, and stem cell research.

5. Market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America.

6. The Biologics Safety Testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

7. The report analyzes factors affecting Biologics Safety Testing market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend

The reports cover key developments in the Biologics Safety Testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Biologics Safety Testing market are anticipated to lucrative growth opportunities in the future with the rising demand for Biologics Safety Testing in the global market. Below mentioned is the list of few companies engaged in the Biologics Safety Testing market.

This reports includes

• Market Overview
• Market Dynamics
• Drivers, Restraints,
• Opportunities & Challenges In Upcoming year
• Market sizing and growth analysis
• Market Competitive Landscape
• Product Launches
• Market Mergers, Acquisitions and Agreements
• Company Profiles

Free 20% | Customization on Pre-Booking :

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

We are committed to providing highest quality research and consulting services to our customers. We help our clients understand key market trends, identify opportunities, and make informed decisions by providing market research solutions at an affordable cost.

Contact us:

The Insight partners,

Phone: +1-646-491-9876


This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biologics Safety Testing Market Future Forecast with Advance Technologies by Top Companies – Lonza, Charles River Laboratories, Cytovance Biologics, Eurofins, Merck Group, WuXi Biologics, Sartorius, Toxikon Corporation here

News-ID: 1733337 • Views: 709

More Releases from The Insight Partners

De-oiled Lecithin Market: Growth Factors, Applications and Regional Analysis and …
The Insight Partners’ report on the De-oiled Lecithin Market aims at developing a better understanding of the De-oiled Lecithin industry through qualitative and quantitative analysis of the key market parameters. The De-oiled Lecithin market is classified on the basis of form, source, and application, and the market is evaluated in terms of growth, value, and volume across five major geographical regions. The report aims to provide an overview of the de-oiled
Wearable Medical Devices Market Worth to be US$ 23,310.9 Million and anticipated …
The latest addition of Wearable Medical Devices market 2027 to The Insight Partners’ store offers major insights on the market size, growth rate, and estimates during the forecast period. It effectively evaluates the market based on device type and application and provides global perspective concerning five major geographical regions. The report would be of an interest to various stakeholders operating in the wearable medical devices market. These stakeholders include healthcare
Automotive Logistics Market Research Report by Geographical Analysis and Forecas …
According to a new market study entitled "Automotive Logistics Market to 2027 - Global Analysis and Forecasts by Deployment Type (On-Premise and Cloud) and Industry Vertical (BFSI, Healthcare & Life Sciences, Retail & Consumer Goods, Manufacturing, Travel & Hospitality, IT & Telecommunication, Media & Entertainment, and Others) and Geography, "explains the report, explaining the key drivers of this growth and highlighting key market players and their evolution. The report factors
Fetal Monitors Market Analysis And Growth Forecast By Applications, Sales, Size, …
To achieve success in the competition of global market place, going for this global Fetal Monitors market research report is the key. The report strategically analyses the growth trends and future prospects. Moreover, this Fetal Monitors market report also provides strategic profiling of top players in the Fetal Monitors industry, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market. Further, it presents the company profile, product

All 5 Releases

More Releases for Biologic

Biologic Injectors Market Insights, Forecast to 2028
Biologic injectors are the injecting devices used to deliver drugs and other substances for biological purposes. Biological products such as drugs, growth hormones, antibodies and other complex biological molecules are administered into the body of an organism through biologic injectors. Biologic injectors are basically used for the treatment of various diseases. Biologic injectors offer different methods of administration such as simple piston, gas, jet and others. They can also be used
Biologic and Medical Imaging Reagents: Global Healthcare Update 2018
Press Release – 10 Jan 2019 Research and Development News -- . . Latest Update "Biologic and Medical Imaging Reagents: Global Markets" with Industries Survey | Global Current Growth and Future. ' ' Report Highlights The global market for biological imaging reagents was valued at $13.2 billion in 2016. This market will grow from $14.4 billion in 2017 to nearly $23.9 billion by 2022 with a compound annual growth rate (CAGR) of 10.6% for the
Biologic Therapeutics Market Insights & Outlook on Industry 2025
Global Biologic Therapeutics Market: Snapshot The branch of science that deals with manufacturing medicines and pharmaceutical products based on biological origins is called biological therapeutics. Any pharmaceutical drug product manufactured from semi-synthesized and biological sources is included under this field. Owing to rapid advances experienced by this sector, a distinct biologic therapeutics market has formed. This market is mainly being driven by a rising demand for better healthcare treatments occurring all
Biologic Therapeutics Market Geographical Outlook by 2025
Global Biologic Therapeutics Market: Overview The global biologic therapeutics market is predicted to benefit from the rising applications of biological products. Biological products could be made of sugars, nucleic acids, proteins, or complex combinations of these substances, or may be living components such as cells and tissues. Biological products are used to prevent diseases, diagnose diseases, or treat or cure medical conditions. Global Biologic Therapeutics Market: Key Trends and Opportunities First and foremost,
Human Hepatitis B Immunoglobulin (IM) Market 2017 - Shanghai RAAS, Hualan Biolog …
Apex Research, recently published a detailed market research study focused on the "Human Hepatitis B Immunoglobulin (IM) Market" across the global, regional and country level. The report provides 360° analysis of "Human Hepatitis B Immunoglobulin (IM) Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Human Hepatitis B Immunoglobulin (IM) industry, and
Global Biologic Drugs Sales Market Report 2017
In this report, the global Biologic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Biologic Drugs for these regions, from 2012 to 2022 (forecast),